
RBI's digital currency rollout: The risks, rewards and the use cases
India is among a handful of nations to have launched the Central Bank Digital Currency (CBDC). Some risks, primarily cyber, are associated with CBDC, although its introduction seeks to make transactions easier. Economic Times looks at the use cases, and challenges CBDC could bring.
UP NEXT
UP NEXT
-
Can digital & foreign universities bridge the gap between higher education and employment?
The Economic Times
-
Budget'23: How can Edtechs build trust in their brands
The Economic Times
-
Budget'23 | Rising Bharat Summit: Strengthening India’s supply chain networks
The Economic Times
-
Govt should incentivise Hydrogen ICE engines through PLI Scheme in the Budget, says Pawan Goenka
The Economic Times
-
Budget'23 | Rising Bharat Summit: How to eliminate the education-jobs mismatch with policy-action synergy
The Economic Times
-
Budget'23: Pawan Goenka on how to make India's automobile industry a global manufacturing hub
The Economic Times
-
Budget'23 | Rising Bharat Summit: Incentivising EVs & manufacturing, how auto industry can grow more
The Economic Times
-
Digital payment growth has not come at the cost of the card networks, says Visa's Sandeep Ghosh
The Economic Times
-
Budget’23 | Rising Bharat Summit: Stimulating growth in an environment of rising macro risks
The Economic Times
-
Budget’23 |Rising Bharat Summit: Tax incentives to allocated funds, what does Fintech want?
The Economic Times
-
Budget’23 | Rising Bharat Summit: India’s challenges in incentivising green growth
The Economic Times
-
Budget'23: What the Indian startup ecosystem needs during this funding winter?
The Economic Times
-
Fund of fund enablement, PE investor participation needed to fuel startup funding, says Prashanth Prakash, Accel Partners
The Economic Times
-
Budget’23 | Rising Bharat Summit: What does Indian startup ecosystem need?
The Economic Times
-
Maruti Suzuki Jimny: Everything you need to know about the 'Thar Killer'
The Economic Times
-
Budget '23: Roche India CEO on why pharma majors are not 'too keen' to bring their medicines to India
The Economic Times